person

Petr Ř.

Country
Czechia
Department
Pediatrická hematologie/onkologie

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
43
Sites with multiple studies

Has run more than one trial at 43 of 86 partner sites.

Specializations

Pediatric Hematology and Leukemia

Petr Riha’s clinical research includes acute lymphoblastic leukemia, acute myeloid leukemia, and other pediatric hematologic malignancies, with a strong focus on treatment strategies for children and adolescents. His trial activity also extends to relapsed and refractory leukemia and stem cell transplantation in childhood blood cancers.

  • Acute lymphoblastic leukemia
  • Acute myeloid leukemia
  • Relapsed/refractory pediatric leukemia
  • Allogeneic stem cell transplantation

His work is closely linked to pediatric hematology/oncology at Fakultni nemocnice Motol a Homolka in Prague.

Pediatric and Adolescent Solid Tumors

His research landscape includes multiple pediatric solid tumors, especially neuroblastoma, Ewing sarcoma, rhabdomyosarcoma, medulloblastoma, and high-grade glioma. He is also involved in studies addressing renal tumors, hepatoblastoma, and atypical teratoid/rhabdoid tumors.

  • Neuroblastoma
  • Ewing sarcoma
  • Rhabdomyosarcoma
  • High-grade glioma and medulloblastoma

These activities reflect a therapeutic interest in difficult-to-treat childhood cancers requiring advanced oncology care.

Immune-Mediated and Rheumatologic Disease

His clinical trial portfolio also covers juvenile idiopathic arthritis, juvenile psoriatic arthritis, psoriatic arthritis, ankylosing spondylitis, and axial spondyloarthritis. Additional interests include atopic dermatitis, hidradenitis suppurativa, systemic lupus erythematosus, and systemic sclerosis.

  • Juvenile idiopathic arthritis
  • Psoriatic arthritis
  • Axial spondyloarthritis
  • Atopic dermatitis

His research includes both pediatric and broader immunology-focused therapeutic areas.

Neurology and Neuroimmunology

Petr Riha is involved in trials in multiple sclerosis, epilepsy, focal seizures, refractory status epilepticus, and autoimmune encephalitis. His portfolio also includes neurodevelopmental and neurodegenerative disorders such as Friedreich's ataxia, frontotemporal dementia, and Alzheimer’s disease.

  • Multiple sclerosis
  • Epilepsy and focal seizures
  • Autoimmune encephalitis
  • Neurodegenerative disease

This area shows engagement with both inflammatory and chronic neurological conditions.

Cardiometabolic, Gastrointestinal, and Other Chronic Disorders

His research interests further include atrial fibrillation, stroke prevention, heart failure, hypercholesterolemia, severe hypertriglyceridemia, type 1 diabetes mellitus, cystic fibrosis, Crohn’s disease, and ulcerative colitis. He is also involved in studies of bladder cancer, prostate cancer, and renal cell carcinoma.

  • Cardiovascular disease and stroke prevention
  • Metabolic disorders
  • Cystic fibrosis and inflammatory bowel disease
  • Urologic and renal cancers

These trials broaden his therapeutic scope across chronic internal medicine and oncology.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.